These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 19833756
21. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW, Childhood Myositis Heterogeneity Collaborative Study Group. Medicine (Baltimore); 2013 Jul; 92(4):223-243. PubMed ID: 23877355 [Abstract] [Full Text] [Related]
22. Immune manifestations of inflammatory muscle disease. Targoff IN. Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326 [Abstract] [Full Text] [Related]
23. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement. Kaji K, Fertig N, Medsger TA, Satoh T, Hoshino K, Hamaguchi Y, Hasegawa M, Lucas M, Schnure A, Ogawa F, Sato S, Takehara K, Fujimoto M, Kuwana M. Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044 [Abstract] [Full Text] [Related]
26. [Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients]. Ghirardello A, Zampieri S, Iaccarino L, Tarricone E, Tonello M, Bendo R, Rondinone R, Cozzi F, Doria A. Reumatismo; 2005 Apr; 57(1):22-8. PubMed ID: 15776143 [Abstract] [Full Text] [Related]
29. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Koenig M, Fritzler MJ, Targoff IN, Troyanov Y, Senécal JL. Arthritis Res Ther; 2007 Apr; 9(4):R78. PubMed ID: 17688695 [Abstract] [Full Text] [Related]
31. Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients. Cooper MA, Willingham DL, Brown DE, French AR, Shih FF, White AJ. Arthritis Rheum; 2007 Sep; 56(9):3107-11. PubMed ID: 17763414 [Abstract] [Full Text] [Related]
32. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580 [Abstract] [Full Text] [Related]
36. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Gunawardena H, Wedderburn LR, Chinoy H, Betteridge ZE, North J, Ollier WE, Cooper RG, Oddis CV, Ramanan AV, Davidson JE, McHugh NJ, Juvenile Dermatomyositis Research Group, UK and Ireland. Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859 [Abstract] [Full Text] [Related]
37. Myositis autoantibodies in a racially diverse population of children with idiopathic inflammatory myopathies. Perron MM, Vasquez-Canizares N, Tarshish G, Wahezi DM. Pediatr Rheumatol Online J; 2021 Jun 12; 19(1):92. PubMed ID: 34118936 [Abstract] [Full Text] [Related]
39. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ, UK Adult Onset Myositis Immunogenetic Collaboration. Ann Rheum Dis; 2009 Oct 12; 68(10):1621-5. PubMed ID: 18930994 [Abstract] [Full Text] [Related]
40. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T. Autoimmunity; 2006 May 12; 39(3):233-41. PubMed ID: 16769657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]